New research indicates that migraine frequency may be inversely linked with a diet high in anti-inflammatory properties.
Greater adherence to a diet with anti-inflammatory properties among migraineurs was significantly and inversely related to headache frequency, according to findings of a cross-sectional study published in Scientific Reports.
Although the exact pathology of migraine remains unknown, previous research has indicated both environmental and genetic factors could play a role; vascular inflammation, corticotropin-releasing hormone, and neurogenic and trigeminovascular system activation have been proposed among other causes.
As dietary factors have been shown to have significant impacts on the modulation of inflammation, researchers utilized the Dietary Inflammatory Index (DII) to better elucidate its association with migraine duration, frequency, and severity of headache.
“The DII score is an index that reflects potential dietary inflammatory properties based on six inflammatory biomarkers, including interleukins (IL)-1β, IL-6, IL-4, IL-10; tumor necrosis factor (TNF)-α; and C-reactive protein (CRP),” authors explained.
Between August 2019 and June 2020, a total of 262 migraineurs in Iran who presented to neurology clinics were enrolled in the study. The majority (n = 224) were women, and all patients were between ages 20 and 50 years.
Participants completed the 168-item semiquantitative Food Frequency Questionnaire (FFQ), which was administered by a skilled dietician. The DII score was calculated based on 32 dietary parameters, and “to get the z-score, the ‘standard global mean’ was subtracted from the quantity of food and divided by the ‘global standard deviation’ (SD),” authors wrote.
Patients also completed the Headache Impact Test-6 (HIT-6) and a 30-day headache diary, with headache severity evaluated via the visual analog scale (VAS) questionnaire. Nitric oxide (NO) was measured using serum samples collected from patients, taken after 8 hours of fasting.
Researchers found that “compared to individuals with the lowest DII scores, those with the highest values had augmented severity of headaches, increased headache frequency, and a greater probability of migraines without aura.”
Those who consumed higher amounts of energy, solid oils, fats and sweets recorded higher DII scores.
Specifically, analyses revealed the following:
Patients in the lowest tertile of DII consumed greater amounts of magnesium, riboflavin, fruits, and vegetables, and previous studies have shown an associated between consumption of these substances and migraine. As such, researchers hypothesized that “higher consumption of these items may be a potential reason to explain migraine-related improvements in the present study.
Presence of residual confounders and potential questionnaire-based bias mark limitations to the current analysis, and authors caution that findings may not be generalizable outside the Iranian population. The study’s cross-sectional design also precludes any conclusions of causation from being drawn.
Reference
Ghoreishy SM, Askari G, Mohammadi H, Campbell MS, Khorvash F, Arab A. Associations between potential inflammatory properties of the diet and frequency, duration, and severity of migraine headahces: a cross-sectional study. Sci Rep. Published online February 21, 2022. doi: 10.1038/s41598-022-06819-y
European Commission Approves Mirvetuximab Soravtansine for FRα+ Platinum-Resistant Ovarian Cancer
November 28th 2024The European Commission has approved mirvetuximab soravtansine for select patients with pretreated folate receptor–alpha (FRα)-positive, platinum-resistant ovarian cancer.
Read More
Venetoclax May Be an Option for Children With R/R AML, MDS
November 27th 2024The single-center report showed the therapy had a favorable safety profile and manageable side effects in children with relapsed or refractory (R/R) acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Read More
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
July 18th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the July 2024 issue of The American Journal of Managed Care® that estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment.
Listen